You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DMFS

Showing 1 - 25 of 253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dental Caries, Hydroxyapatite, Tooth Decay Trial in Poznan (Experimental., Active comparator)

Completed
  • Dental Caries
  • +4 more
  • Experimental.
  • Active comparator
  • Poznań, Poland
    Poznan University of Medical Sciences
Jan 9, 2023

Early Childhood Caries, Dental Caries Trial in Kykotsmovi, Crow Agency (Oral Health, Healthy Lifestyle)

Terminated
  • Early Childhood Caries
  • Dental Caries
  • Oral Health
  • Healthy Lifestyle
  • Kykotsmovi, Arizona
  • +1 more
Jul 11, 2022

High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)

Recruiting
  • High-grade Salivary Gland Carcinoma
  • nivolumab, docetaxel, cisplatin Group
  • Seoul, Korea, Republic of
    Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 3, 2023

Merkel Cell Carcinoma Trial in Germany, Netherlands (Nivolumab)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Essen, NRW, Germany
  • +19 more
Jan 5, 2022

HNSCC, Radiotherapy, PD-1 Trial in Guangzhou (PD-1inhibitor, concurrent chemoradiotherapy)

Recruiting
  • HNSCC
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Clinical Stage IIA Cutaneous Melanoma AJCC v8
  • Portland, Oregon
    OHSU Knight Cancer Institute
Nov 27, 2023

Acquired Brain Injury, Fatigue Trial (e-COGRAT (a blended eHealth intervention))

Not yet recruiting
  • Acquired Brain Injury
  • Fatigue
  • e-COGRAT (a blended eHealth intervention)
  • (no location specified)
May 8, 2023

Breast Cancer Stage II Trial in France, Portugal, Spain (Ribociclib (neoadjuvant), Chemotherapy (adjuvant), Ribociclib

Recruiting
  • Breast Cancer Stage II
  • Ribociclib (neoadjuvant)
  • +2 more
  • Avignon, France
  • +49 more
Jul 7, 2022

Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body

Not yet recruiting
  • Pancreas Cancer
  • +2 more
  • Stereotactic Ablative Body Radiation (SABR)
  • Tumor Treating Fields (TTF)
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022

Tooth Decay Trial in Montpellier (decayed tooth surfaces)

Completed
  • Tooth Decay
  • decayed tooth surfaces
  • Montpellier, France
    MOULIS
Aug 10, 2022

Melanoma Trial in Nedlands, Haifa, Jerusalem (Pembrolizumab/Vibostolimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Pembrolizumab/Vibostolimab
  • Pembrolizumab
  • Nedlands, Western Australia, Australia
  • +2 more
Jan 31, 2023

Rectal Cancer Patients Based on ctDNA-MRD Technology

Recruiting
  • Rectal Adenocarcinoma
  • +3 more
  • MRD detection
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Jul 31, 2023

Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)

Recruiting
  • Neoadjuvant
  • +3 more
  • Pembrolizumab, Eftilagimod alpha
  • Warsaw, Poland
    Maria Sklodowska-Curie National Research Institute of Oncology
Nov 7, 2023

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in China (Nimotuzumab, Gemcitabine, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • Baise, Guangxi, China
  • +8 more
Jan 29, 2023

Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Dec 20, 2022

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma

Active, not recruiting
  • Melanoma
  • Dabrafenib and Trametinib
  • Buxtehude, Niedersachsen, Germany
  • +35 more
Aug 25, 2022

Melanoma Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Melanoma
  • V940
  • +2 more
  • (no location specified)
Jul 12, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Shanghai (Endostar,

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 17, 2023

Pancreatic Carcinoma Trial in Shanghai (carbon ion radiotherapy)

Recruiting
  • Pancreatic Carcinoma
  • carbon ion radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Apr 25, 2023

Nasopharyngeal Carcinoma Trial in China (Endostatin and Capecitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Endostatin and Capecitabine
  • Hangzhou, Zhejiang, China
  • +6 more
Aug 21, 2022

Early Childhood Caries Trial in Alexandria (Sodium Fluoride Varnish (5%), Motivational Interviewing, SDF)

Active, not recruiting
  • Early Childhood Caries
  • Sodium Fluoride Varnish (5%)
  • +2 more
  • Alexandria, Egypt
    Alexandria University
Feb 27, 2023

Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

Completed
  • Breast Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022

Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • dose-reduced radiotherapy
  • Zhuhai, Guangdong, China
    Fifth Affiliated Hospital of Sun Yat-sen University
May 3, 2023